OCLN gene

Last updated on: 28.02.2024

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The OCLN gene (Occludin) is a protein coding gene localized on chrom0some 5q13.2. This gene encodes an integral membrane protein(occludin) that is required for cytokine-induced regulation of the paracellular permeability barrier of tight junctions. Alternative splicing leads to several transcript variants. An important paralog of this gene is MARVELD2. A related pseudogene is located 1.5 Mb downstream on the q arm of chromosome 5.

General informationThis section has been translated automatically.

The membrane protein occludin is able to induce adhesion when expressed in cells lacking tight junctions. Occludin acts as a co-receptor for the hepatitis C virus (HCV) in hepatocytes.

Mutations in this gene are thought to be the cause of band-like calcification with simplified gyrations and polymicrogyria (BLC-PMG - Jenkinson EM et al. 2018), an autosomal recessive neurological disorder also known as pseudo-TORCH syndrome (Ekinci F et al. 2020).

LiteratureThis section has been translated automatically.

  1. Bamforth SD et al. (1999) A dominant mutant of occludin disrupts tight junction structure and function. J Cell Sci 112: 1879-1888.
  2. Ekinci F et al. (2020) A homozygous frameshift mutation in OCLN gene result in Pseudo-TORCH syndrome type I: A case report extending the phenotype with central diabetes insipidus and renal dysfunction. Eur J Med Genet 63:103923.
  3. Jenkinson EM et al. (2018) Comprehensive molecular screening strategy of OCLN in band-like calcification with simplified gyration and polymicrogyria. Clin Genet 93:228-234.
  4. Furuse M et al. (1993) Occludin a novel integral membrane protein localizing at tight junctions. In: J Cell Biol 123: 1777-1788.
  5. Gemma J et al. (2005) Occludin: Structure, function and regulation. In: Adv Drug Deliv Rev. 57: 883-917.
  6. Kuo WT et al. (2022) Tight junction proteins occludin and ZO-1 as regulators of epithelial proliferation and survival. Ann N Y Acad Sci 1514:21-33.
  7. Kuo WT et al. (2019) Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression. Gastroenterology 157:1323-1337.
  8. Mankertz J etal. (2002) Gene expression of the tight junction protein occludin includes differential splicing and alternative promoter usage. Biochem Biophys Res Commun 298: 657-66
  9. Muresan Z et al. (2000) Occludin 1B, a variant of the tight junction protein occludin. Mol Biol Cell 11: 627-634.
  10. Sugita K et al. (2020) Tight junctions in the development of asthma, chronic rhinosinusitis, atopic dermatitis, eosinophilic esophagitis, and inflammatory bowel diseases. J Leukoc Biol 107:749-762.

Last updated on: 28.02.2024